Spinal cord stimulation therapy is almost always introduced through a two-stage process: a temporary spinal cord stimulator trial followed, only if successful, by permanent implantation. This structure exists because individual response to stimulation cannot be reliably predicted in advance, and committing directly to a permanent implanted device without first confirming meaningful benefit would expose patients to unnecessary surgical risk without evidence the therapy will actually help them.
What Happens During the Stimulator Trial Period?
During the stimulator trial period, thin electrode leads are placed near the spinal cord using a minimally invasive needle-based technique, typically without a permanent incision or implanted generator. These leads are connected to a small external stimulator device that the patient wears or carries for the duration of the trial, generally lasting anywhere from several days to about a week. Patients use the device in their normal daily environment, going about typical activities as much as possible, since the goal is to assess real-world effectiveness rather than results in a clinical setting alone.
How Is Success Measured During the Trial?
Success criteria for a spinal cord stimulator trial generally center on the degree of pain reduction reported by the patient, along with improvements in function, such as increased ability to perform daily activities or reduced reliance on pain medication. A substantial reduction in the patient's baseline pain level, commonly a significant percentage improvement, sustained throughout the trial period, is typically the benchmark used to determine whether the therapy is providing meaningful benefit. Patients are often asked to keep a pain diary or complete standardized questionnaires during this period to help the physician make an objective assessment rather than relying on a single follow-up conversation.
What Happens After a Successful Trial?
If the trial meets the agreed success criteria, the temporary leads are removed, and a decision is made to proceed with permanent implantation. This involves a more definitive procedure to place permanent electrode leads and implant a small pulse generator under the skin, typically in the abdomen or upper buttock area. The permanent system allows for long-term programming and adjustment and is intended to provide ongoing therapy rather than the temporary experience offered during the trial phase.
What Happens If the Trial Is Not Successful?
If the stimulator trial period does not achieve adequate pain relief or functional improvement, the temporary leads are simply removed, and the patient does not proceed to permanent implantation. This outcome does not necessarily mean all neuromodulation options are exhausted; a physician may consider adjusting lead placement or stimulation parameters and repeating a trial, or may recommend an alternative pain management pathway altogether. The trial's reversibility is intentional, allowing patients and physicians to make an informed decision before committing to a permanent device.
Who Guides the Decision Between Trial and Implant?
Because the decision to proceed to permanent implantation depends on both objective trial results and the patient's own assessment of benefit, a qualified physician reviews trial outcomes collaboratively with the patient before recommending the next step. Psychological evaluation, addressing factors that can influence chronic pain and treatment response, is also commonly part of the overall assessment process before a spinal cord stimulator trial is even initiated, reflecting the comprehensive evaluation this two-stage pathway is designed to support.
Can the trial be repeated if the first attempt does not work?
In some cases, a physician may consider adjusting lead position or stimulation settings and repeating a trial, particularly if there is reason to believe the initial trial did not adequately test the therapy's potential. This decision depends on the specific circumstances and is made collaboratively between physician and patient.
Device availability and regulatory status vary by country. Please contact INVAMED or your authorized local distributor for current regulatory information applicable to your region.